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Background & Aims: Autoimmune hepatitis (AIH), an immune-
mediated liver disease, originates as a consequence of interacting
genetic and environmental risk factors. Treatment remains non-
specific and prone to side effects. Deficiencies in regulatory T cell
(Treg) function are hypothesized to contribute to the pathogene-
sis of AIH.
Methods:We describe an adult patient who presented with AIH
in the context of monocytopenia. The patient was characterized
by GATA2 gene sequencing, flow cytometry of peripheral blood
for leucocyte subsets, ELISA for serum Flt-3 ligand, and immuno-
histochemistry of liver biopsy tissue.
Results: Sequencing confirmed a GATA2 mutation. Peripheral
Treg were absent in the context of a preserved total T cell count.
Immunostaining for the Treg transcription factor FOXP3 was
reduced in liver tissue as compared to a control AIH specimen.
There were marked deficiencies in multiple antigen-presenting
cell subsets and Flt-3 ligand was elevated. These findings are con-
sistent with previous reports of GATA2 dysfunction.
Conclusions: The association of a GATA2 mutation with AIH is
previously unrecognized. GATA2 encodes a hematopoietic cell
transcription factor, and mutations may manifest as monocy-
topenia, dendritic and B cell deficiencies, myelodysplasia, and
immunodeficiency. Tregs may be depleted as in this case. Our
findings provide support for the role of Tregs in AIH, complement
reports of other deficiencies in T cell regulation causing AIH-like
syndromes, and support the rationale of attempting to modulate
the Treg axis for the therapeutic benefit of AIH patients.
 2016 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Journal of Hepatology 20
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Autoimmune hepatitis (AIH) is an immune-mediated liver dis-
ease with environmental and genetic risk factors. Deficits in
immunoregulation, most notably regulatory T cell (Treg) func-
tion, are associated with etiopathogenesis [1].
HLA associations with AIH represent the strongest genetic risk
factors, implying specific immune presentation of triggering anti-
gens [2]. Rare Mendelian genetic variation is additionally mecha-
nistically informative, with strong association between AIH and
recessive mutations in the autoimmune regulator gene, AIRE
[3]. Such mutations prevent the thymic medulla presenting
tissue-restricted antigens to developing T cells, impairing both
negative selection of autoreactive cells and generation of self-
specific Tregs. Furthermore, murine immune-mediated hepatitis
can be generated by medullary thymic epithelial cell depletion
through deletion of TRAF6 and Treg deficiency causes peri-
portal inflammation [4,5].
We report and characterize AIH associated with a mutation in
GATA2, a novel observation with mechanistic and therapeutic
insights.Patient
Ourpatient, of EuropeanCaucasianancestryandwithout familyhis-
tory of note, presented at age 27, but gave a history of lymphedema,
possible porphyria cutanea tarda, and intermittent superficial skin
infections as a teenager. Aged 21 she developed trilineage cytope-
nias includingmonocytopenia initially diagnosed asmyelodysplas-
tic syndrome (MDS). Bonemarrowaspiration revealed absolute loss
of multi-lymphoid and granulocyte-macrophage progenitors in a
hypocellular marrow. She developed an erythrocyte transfusion
requirement and her infections became more frequent.
Aged 27, she developed elevated liver biochemistry consistent
with hepatitis, which resolved spontaneously. Aged 28, whilst
free of medical immunosuppression, she developed hepatitis
with ascites. Ultrasound and magnetic resonance cholangiopan-
creatography showed hepatosplenomegaly and showed no evi-
dence of biliary disease. Total IgG was elevated peaking at16 vol. 64 j 1190–1193
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Fig. 1. Liver histopathology. (A) Transjugular liver biopsy sample demonstrating
dense lymphocytic infiltrate with interface hepatitis consistent with AIH
(haematoxylin and eosin; 20). (B) Fibrosis bridging between portal areas (Van
Gieson; 20). (C and D) Cells positive for the Treg transcription factor FOXP3
were scant in the inflammatory infiltrate of patient liver (C), but more frequent in
a control AIH sample (D) (both 32; example positive staining denoted by
arrowheads). (E and F) CD20-positive B cells were present in patient liver biopsy
specimen (E) in contrast to peripheral blood but at a reduced frequency to a
control AIH sample (F; 32). (This figure appears in colour on the web.)
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41.05 g/L, polyclonal and predominantly IgG1. Anti-nuclear anti-
bodies were positive at 1:100 in a speckled pattern; other
autoantibodies including anti-mitochondrial antibody were neg-
ative (Supplementary Tables 1 and 2). Liver biopsy revealed
plasma cells and interface hepatitis consistent with AIH (Fig. 1).
There was mild macrovesicular steatosis, moderate iron deposi-
tion consistent with previous repeated transfusions and moder-
ate fibrosis; staining suggestive of alternate etiologies was
negative, including specific staining for Epstein-Barr virus (EBV;
Supplementary materials). An EBV viral load of 104–105 copies/
ml was present throughout; no other viral factors were identified
including negative PCR for hepatitis B, C, E and cytomegalovirus.
Human leukocyte antigen (HLA) genotyping revealed non-AIH
risk alleles: HLA-DPB1⁄03:01 and HLA-DPB1⁄10:01 (Supplemen-
tary Table 3). Functional antibody testing confirmed preserved
ability to generate antigen-specific responses (Supplementary
Table 4).
Corticosteroids were commenced as prednisolone 40 mg/day,
and her ascites and liver biochemistry tests resolved. Shortly
afterwards, she developed JC/polyoma virus-positive progressive
multifocal leukoencephalopathy (PML). Corticosteroids were dis-
continued, PML treatment commenced, and she regained the
ability to walk. On discontinuing corticosteroids, her liver bio-
chemistry again deteriorated. Over subsequent years she received
variable corticosteroid-tacrolimus immunosuppression without
recurrence of PML but with varying elevations in transaminases.
Repeat liver biopsy at the age of 32 showed similar features
with progressing fibrosis. She later developed human papilloma
virus-associated vulval carcinoma, which was treated with radio-
therapy. At this point investigations were initiated for suspected
GATA2 mutation.
After investigations confirmed GATA2 mutation, hematopoi-
etic stem cell transplantation was performed. The allograft was
unsuccessful and the patient ultimately died from complications
of vulval carcinoma.Table 1. Leucocyte subtypes.
Parameter Normal range This patient
Leucocyte subtypes (×104/ml)
   T cells 91.9-201.9 343.3
   CD4+ T cells 30-140 80
   CD8+ T cells 20-90 130
   B cells 3.3-28.9 0.6
   NK cells 7.9-52.5 0.05
Antigen presenting cells (×104/ml)
CD14+ monocytes 31.5-59.7 7.2
CD16+ monocytes 2.1-8.2 0.18
CD1c+ dendritic cells 0.7-2.0 0.006
CD141+ dendritic cells 0.05-0.19 0.000
Plasmacytoid dendritic cells 0.8-2.2 0.003
CD34+ progenitors 0.1-0.5 0.46Results
DNA sequencing revealed a coding 1081C>T R361C abnormality
in exon 7 of GATA2. Serum Fms-like tyrosine kinase 3 ligand
(Flt-3L) was markedly elevated at 1267.2 pg/ml (normal 48.3–
173.8 pg/ml); sequencing for Flt-3 receptor mutations was nega-
tive. Flow cytometry demonstrated marked reductions in num-
bers of dendritic cells, monocytes, B and natural killer (NK)
cells in keeping with ‘DCML deficiency’ [6] (Table 1). There was
a maintained T cell population but near absence of FOXP3+ Treg
(Fig. 2; Supplementary Fig. 1). Sparse FOXP3+ cells were seen in
the hepatic inflammatory infiltrate and fewer than when com-
pared to control AIH, or prior reports (Fig. 1) [7]. In situ hybridiza-
tion staining was negative for EBV (Supplementary Fig. 2).
The calculated AIH score according to the International
autoimmune hepatitis group revised diagnostic scoring system
was 21 with a score >17 suggesting definite AIH (Table 2).Discussion
Specific therapy in AIH is limited by our understanding of disease
etiopathogenesis. Here we demonstrate the association of a mis-
sense mutation in GATA2, a hematopoietic transcription factor,Journal of Hepatology 2016with classical AIH and systemic Treg deficiency. This new molec-
ular insight in AIH supports the relevance of developing novel
therapies focused on reconstituting regulatory balance.
GATA2 dysfunction may present in the first two decades with
lymphedema, deafness and myelodysplasia (Emberger syn-
drome), or acute myeloid leukemia without preceding immunod-
eficiency [8]. Presentation may also be with non-tuberculous
mycobacterial infections and monocytopenia, DCML deficiencyvol. 64 j 1190–1193 1191
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Fig. 2. Immunophenotyping by flow cytometry. (A) Flow cytometric analysis of peripheral blood demonstrated antigen-presenting cell deficiencies and leukocytopenias
in multiple subsets with preserved total T cells. (B) Analysis of T cell populations revealed minimal CD25lowCD127hi cells and no evidence of expression of the transcription
factor FOXP3 in a patient sample. This confirmed a marked deficiency in Treg. Approximately 8% of peripheral CD4+ T cells were CD25lowCD127hiFOXP3+Treg in a control
sample. The absence of CD3-negative cells (blue gate, second panel) highlights B- and NK-cell deficiency. CD4:CD8 ratio was altered from the CD4-predominance seen in
normality to equality, as reported in GATA2 dysfunction. (This figure appears in colour on the web.)
Case Reportor familial MDS/acute myeloid leukemia [9,10]. Related carriers
may remain healthy for decades. The cause of the variable age
of onset may be unidentified environmental exposures or addi-
tional genetic risk, for example AXL1 mutation [5]. Most individ-
uals with GATA2 dysfunction develop MDS; elevated serum Flt-3
ligand is almost universal [11]. Monocytopenia is a vital clue to
this rare diagnosis; chronic neutropenia and NK deficiency may
also be suggestive [9]. This is the first characterization of associ-
ated AIH, but autoimmune phenomena including arthritis and
hypothyroidism are recognized [11].
Several features support the diagnosis of AIH: plasma cells
and interface hepatitis on liver biopsy, steroid responsiveness
with relapse on withdrawal, the presence of anti-nuclear anti-
body and elevated serum IgG. IgG is usually normal in GATA2
dysfunction, despite the near absence of peripheral B cells [5].
In our case, B cells were present in the hepatic inflammatory infil-
trate but not peripherally, suggesting local induction. The differ-
ential diagnosis of EBV-driven hepatitis was made unlikely by
steroid responsiveness, stable viremia and negative in situ
hybridization assay. We note that EBV viremia was reported
amongst 11% of one cohort of patients with monoMAC but hep-
atitis was not reported [8].
The increase in absolute and relative numbers of CD8 T cells in
the peripheral blood of this patient is of interest. CD8 cells have1192 Journal of Hepatology 2016been implicated in the pathogenesis of AIH: they are present in
the inflammatory infiltrate, cells isolated from those with active
disease may be resistant to regulation be more resistant than
usual to regulation by Treg [1]. In addition, several animal models
of AIH demonstrate increases in both peripheral and hepatic CD8
+ T cell numbers [1]. Serum soluble CD8, which is increased in
CD8 T cell activation, is also reported to be elevated in AIH.
Although it is tempting to link the elevation in CD8+ T cells to
AIH, it is notable that accumulation of CD8+ T cells is a feature
of progressing GATA2 dysfunction without AIH [11].
Of particular interest in this patient is the Treg deficiency
despite preserved numbers of total CD4+ and CD8+ T cells. Tregs
may be depleted in association with dendritic cell deficiency,
including in GATA2 dysfunction [12,13]. We speculate that this
deficiency may have contributed to a loss of immunological toler-
ance. Sparse FOXP3 staining on liver biopsymay reflect activated T
cells transiently expressing FOXP3 or alternatively induced/trans-
differentiated Treg in an inflammatory environment [14]. Reduced
CD127 expression on peripheral T cells was consistent with
impairedmemory cell induction as reported inGATA2 dysfunction
[11]. This may have contributed to a susceptibility to viral
infections.
The association of a functional mutation in GATA2 with AIH
and Treg deficiency informs efforts to further examine regulatoryvol. 64 j 1190–1193
Table 2. International autoimmune hepatitis group revised diagnostic scoring
system.
Parameter Feature Score This case
Gender Female +2 2
ALP:AST (or ALT) ratio >3 -2
1.5-3 0 0
<1.5 +2
Serum IgG (×ULN) >2 +3 3
1.5-2 +2
1-1.5 +1
ANA, SMA or anti-LKM-1 titres >1:80 +3 3
1:80 +2
1:40 +1
<1:40 0
AMA Positive -4 0
Viral markers of active infection Positive -3
Negative +3 3
Hepatotoxic drug history Yes -4
No +2 2
Average alcohol consumption <25 g/day +2 2
>60 g/day -2
Histological features Interface 
hepatitis
+3 3
Plasma cells +1 1
Rosettes +1
None of the 
above
-5
Biliary 
changes
-3 -3
Atypical 
changes
-3
Other immune disease Yes +2 2
HLA DR3 or DR4 +1 0*
Seropositivity for anti-SLA/LP, actin, 
ASGPR or pANNA
Yes +2 0
Response to therapy Remission +2
Remission-
relapse
+3 3
Total: 21
A score of 12-17 denotes possible AIH; >17 definite AIH
⁄HLA type = HLA-DPB1⁄03:01, DPB1⁄10:01.
JOURNAL OF HEPATOLOGYmechanisms in AIH to better understand pathogenesis and guide
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